Research programme: next-generation HIV gp120 vaccines - VaxGen
Latest Information Update: 19 Sep 2006
At a glance
- Originator VaxGen
- Class AIDS vaccines
- Mechanism of Action Immunostimulants
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
Highest Development Phases
- Discontinued HIV infections
Most Recent Events
- 19 Sep 2006 Discontinued - Preclinical for HIV infections prevention in USA (unspecified route)
- 12 Jun 2003 Preclinical trials in HIV infections prevention in USA (unspecified route)